Medigus Ltd. (MDGS)
Stock Price:
$1.64 USD
0.02 (1.23%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
Pre-market: $1.56 -0.08 (-4.88%) Aug 10, 4:55 AM
Key Info
| Market Cap |
12.56M |
| Revenue (ttm) |
273,000 |
| Net Income (ttm) |
-14.18M |
| Shares Out |
7.66M |
| EPS (ttm) |
-3.62 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 7, 2020 |
| Last Price |
$1.64 |
| Previous Close |
$1.62 |
| Change ($) |
0.02 |
| Change (%) |
1.23% |
| Day's Open |
1.62 |
| Day's Range |
1.57 - 1.67 |
| Day's Volume |
135,292 |
| 52-Week Range |
0.83 - 5.15 |
More Stats
| Market Cap |
12.56M |
| Enterprise Value |
5.68M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
7.66M |
| Float |
2.66M |
| EPS (basic) |
-0.9 |
| EPS (diluted) |
-3.62 |
| FCF / Share |
-0.19 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
50,953 |
| Short Ratio |
0.16 |
| Short % of Float |
n/a |
| Beta |
1.26 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
46.01 |
| PB Ratio |
1.85 |
| Revenue |
273,000 |
| Operating Income |
-14.20M |
| Net Income |
-14.18M |
| Free Cash Flow |
-2.82M |
| Net Cash |
6.88M |
| Net Cash / Share |
0.90 |
| Gross Margin |
-66.67% |
| Operating Margin |
-5,202.93% |
| Profit Margin |
-5,193.40% |
| FCF Margin |
-1,032.60% |
| ROA |
-21.36% |
| ROE |
-174.93% |
| ROIC |
-3,853.00% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
159
Current: $1.64
High
159
Target: 158.61
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|
| Revenue | 0.27 | 0.44 | 0.47 | 0.55 | 0.62 | 0.74 |
| Revenue Growth | -37.39% | -6.64% | -14.94% | -12.02% | -16.13% | - |
| Gross Profit | -0.18 | -0.17 | -0.05 | 0.37 | 0.35 | 0.39 |
| Operating Income | -14.20 | -6.67 | -6.11 | -9.09 | -9.56 | -8.25 |
| Net Income | -14.18 | -6.60 | -2.55 | -9.01 | -9.53 | -6.36 |
| Shares Outstanding | 75.93 | 47.95 | 11.04 | 8.60 | 7.10 | 4.88 |
| Earnings Per Share | -0.90 | -0.80 | -1.15 | -13.10 | -6.80 | -6.60 |
| Operating Cash Flow | -2.76 | -4.25 | -4.66 | -9.26 | -6.97 | -7.78 |
| Capital Expenditures | -0.06 | -0.01 | -0.01 | -0.03 | -0.08 | -0.07 |
| Free Cash Flow | -2.82 | -4.26 | -4.67 | -9.29 | -7.05 | -7.85 |
| Cash & Equivalents | 7.04 | 10.63 | 6.33 | 3.00 | 10.31 | 12.92 |
| Total Debt | 0.15 | - | - | - | - | - |
| Net Cash / Debt | 6.88 | 10.63 | 6.33 | 3.00 | 10.31 | 12.92 |
| Assets | 13.33 | 11.24 | 7.21 | 4.72 | 12.14 | 14.29 |
| Liabilities | 5.20 | 3.16 | 1.70 | 1.80 | 1.96 | 1.24 |
| Book Value | 6.71 | 8.08 | 5.51 | 2.93 | 10.18 | 13.05 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Medigus Ltd. |
| Country |
Israel |
| Employees |
20 |
| CEO |
Liron Carmel |
Stock Information
| Ticker Symbol |
MDGS |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: MDGS |
Description
Medigus Ltd., a medical device company, develops, produces, and markets minimally invasive endo-surgical tools and direct visualization technology in the United States, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also provides miniaturized digital video cameras and video processing equipment for use in medical applications, as well as industrial applications. Medigus Ltd. was founded in 1999 and is headquartered in Omer, Israel.